Evidence map›Paper›PMID 36179666›Full record

ArticleCell2022

Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomes.

Alessa R Ringel, Quentin Szabo, Andrea M Chiariello, Konrad Chudzik, Robert Schöpflin, Patricia Rothe, Alexandra L Mattei, Tobias Zehnder, Dermot Harnett, Verena Laupert and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Remodeling ofScience advances · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Bridging spatial and temporal scales of developmental gene regulation.Current opinion in genetics & development · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genomic context sensitizes regulatory elements to genetic disruption.bioRxiv : the preprint server for biology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 6 countries.

Alessa R RingelMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Quentin SzaboInstitute of Human Genetics, University of Montpellier, CNRS, Montpellier, France.
Andrea M ChiarielloDipartimento di Fisica, Università di Napoli Federico II and INFN Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.
Konrad ChudzikMax Planck Institute for Molecular Genetics, Berlin, Germany.
Robert SchöpflinMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Patricia RotheMax Planck Institute for Molecular Genetics, Berlin, Germany.
Alexandra L MatteiMax Planck Institute for Molecular Genetics, Berlin, Germany; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Tobias ZehnderMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Dermot HarnettBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Verena LaupertMax Planck Institute for Molecular Genetics, Berlin, Germany.
Simona BiancoDipartimento di Fisica, Università di Napoli Federico II and INFN Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.
Sara HetzelMax Planck Institute for Molecular Genetics, Berlin, Germany.
Juliane GlaserMax Planck Institute for Molecular Genetics, Berlin, Germany.
Mai H Q PhanMax Planck Institute for Molecular Genetics, Berlin, Germany; Charité-Universitätsmedizin Berlin, BCRT-Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.
Magdalena SchindlerMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Daniel M IbrahimMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, BCRT-Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.
Christina PaliouCentro Andaluz de Biología del Desarrollo (CABD), Consejo Superior de Investigaciones Científicas/Universidad Pablo de Olavide, Seville, Spain.
Andrea EspositoDipartimento di Fisica, Università di Napoli Federico II and INFN Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy.
Cesar A Prada-MedinaMax Planck Institute for Molecular Genetics, Berlin, Germany; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Stefan A HaasMax Planck Institute for Molecular Genetics, Berlin, Germany.
Peter GiereMuseum für Naturkunde, Leibniz Institute for Evolution and Biodiversity Science, Berlin, Germany.
Martin VingronMax Planck Institute for Molecular Genetics, Berlin, Germany.
Lars WittlerMax Planck Institute for Molecular Genetics, Berlin, Germany.
Alexander MeissnerMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Mario NicodemiDipartimento di Fisica, Università di Napoli Federico II and INFN Napoli, Complesso Universitario di Monte Sant'Angelo, Naples, Italy; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Giacomo CavalliInstitute of Human Genetics, University of Montpellier, CNRS, Montpellier, France.
Frédéric BantigniesInstitute of Human Genetics, University of Montpellier, CNRS, Montpellier, France.
Stefan MundlosMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, BCRT-Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany. Electronic address: mundlos@molgen.mpg.de.
Michael I RobsonMax Planck Institute for Molecular Genetics, Berlin, Germany; Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany; Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Electronic address: robson@molgen.mpg.de.
Max Planck Institute for Molecular Genetics · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECentre National de la Recherche Scientifique · FRIstituto Nazionale di Fisica Nucleare, Sezione di Napoli · ITMax Delbrück Center · DEBerlin-Brandenburger Centrum für Regenerative Therapien · DEBroad Institute · USConsejo Superior de Investigaciones Científicas · ESHarvard University · USMuseum für Naturkunde · DEUniversity of Oxford · GB

Funding

Wellcome TrustWellcome Trust 206475/Z/17/ZWellcome Trust ALTF1554-2016
6 · The paper itself

Abstract

Regulatory landscapes drive complex developmental gene expression, but it remains unclear how their integrity is maintained when incorporating novel genes and functions during evolution. Here, we investigated how a placental mammal-specific gene, Zfp42, emerged in an ancient vertebrate topologically associated domain (TAD) without adopting or disrupting the conserved expression of its gene, Fat1. In ESCs, physical TAD partitioning separates Zfp42 and Fat1 with distinct local enhancers that drive their independent expression. This separation is driven by chromatin activity and not CTCF/cohesin. In contrast, in embryonic limbs, inactive Zfp42 shares Fat1's intact TAD without responding to active Fat1 enhancers. However, neither Fat1 enhancer-incompatibility nor nuclear envelope-attachment account for Zfp42's unresponsiveness. Rather, Zfp42's promoter is rendered inert to enhancers by context-dependent DNA methylation. Thus, diverse mechanisms enabled the integration of independent Zfp42 regulation in the Fat1 locus. Critically, such regulatory complexity appears common in evolution as, genome wide, most TADs contain multiple independently expressed genes.

Indexed as

ChromatinPlacentaAnimalsCCCTC-Binding FactorChromatin Assembly and DisassemblyEnhancer Elements, GeneticEvolution, MolecularFemaleGenomeMammalsPregnancyPromoter Regions, GeneticTranscription FactorsCCCTC-Binding FactorChromatinTranscription Factors3D genome organizationcohesinCTCFdevelopmental gene regulationDNA methylationenhancer-promoter specificityevolutionlamina-associated domainloop extrusiontopologically associating domains

Identifiers

PMID36179666
PMCPMC9567273
OpenAlexW4298008797

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.